WP
GILD icon

Woodline Partners’s Gilead Sciences GILD Stock Holding History

Woodline Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.8M Buy
528,600
+27,959
+6% +$3.68M 0.21% 126
2026
Q1 		$69.8M Buy
500,641
+33,346
+7% +$4.67M 0.26% 83
2025
Q4 		$57.4M Buy
467,295
+27,393
+6% +$3.33M 0.22% 109
2025
Q3 		$48.8M Sell
439,902
-125,047
-22% -$14.2M 0.23% 115
2025
Q2 		$62.6M Sell
564,949
-185,567
-25% -$19.7M 0.33% 66
2025
Q1 		$84.1M Buy
750,516
+15,823
+2% +$1.63M 0.55% 27
2024
Q4 		$67.9M Sell
734,693
-1,193,336
-62% -$107M 0.46% 45
2024
Q3 		$162M Buy
1,928,029
+921,537
+92% +$70.3M 1.36% 2
2024
Q2 		$69.1M Buy
1,006,492
+5,713
+0.6% +$381K 0.66% 34
2024
Q1 		$73.3M Sell
1,000,779
-463,362
-32% -$35.6M 0.67% 27
2023
Q4 		$119M Buy
1,464,141
+763,205
+109% +$59.4M 1.29% 8
2023
Q3 		$52.5M Buy
700,936
+42,736
+6% +$3.29M 0.62% 35
2023
Q2 		$50.7M Buy
658,200
+208,421
+46% +$16.6M 0.6% 42
2023
Q1 		$37.3M Buy
449,779
+45,946
+11% +$3.81M 0.51% 44
2022
Q4 		$34.7M Sell
403,833
-1,858,858
-82% -$147M 0.46% 47
2022
Q3 		$140M Buy
2,262,691
+1,844,728
+441% +$116M 1.95% 3
2022
Q2 		$25.8M Sell
417,963
-3,744
-0.9% -$232K 0.4% 76
2022
Q1 		$25.1M Sell
421,707
-228,381
-35% -$14.6M 0.41% 68
2021
Q4 		$47.2M Sell
650,088
-430,079
-40% -$29.6M 0.68% 32
2021
Q3 		$75.5M Hold
1,080,167
– – 1.23% 9
2021
Q2 		$74.4M Sell
1,080,167
-461,726
-30% -$30.8M 1.39% 10
2021
Q1 		$99.7M Buy
+1,541,893
New +$99.4M 2.21% 3
2020
Q3 		– Sell
-153,614
Closed -$11.8M – 192
2020
Q2 		$11.8M Buy
+153,614
New +$11.8M 0.47% 65
2020
Q1 		– Sell
-847,869
Closed -$55.1M – 152
2019
Q4 		$55.1M Buy
+847,869
New +$55.2M 2.25% 12

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Woodline Partners's GILD Position: Q2 2026 in Review

Woodline Partners increased its Gilead Sciences (GILD) stake by 5.6% in Q2 2026, buying an estimated $3.68M and bringing the position to 528,600 shares worth $66.8M. The position accounts for 0.21% of the portfolio, ranked #126.

Woodline Partners first reported a position in GILD in Q4 2019 and has held it in 24 quarters since. The position peaked at $162M in Q3 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Woodline Partners held 528,600 shares of Gilead Sciences worth $66.8M as of Q2 2026.
  • Woodline Partners bought 27,959 Gilead Sciences shares in Q2 2026, an estimated $3.68M.
  • Gilead Sciences made up 0.21% of Woodline Partners's portfolio in Q2 2026, its #126 holding.
  • Woodline Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 24 quarters since.
  • Woodline Partners's Gilead Sciences position peaked at $162M in Q3 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.